In the UK, the approval of a novel coronavirus infection (Corona 19) vaccine jointly developed by Oxford University and AstraZeneca is imminent, Telegraph reported on the 23rd (local time).
Health Minister Matt Hancock said on the day, “We are pleased to announce that the entire data for the Oxford University-AstraZeneca vaccine developed here in the UK has been submitted to the Pharmaceutical and Health Care Product Regulatory Authority (MHRA) for approval.”
Government officials expect the University of Oxford vaccine to be approved early next week. In particular, MHRA experts are expected to agree on approval by the 28th or 29th, which will continue to work during Christmas, Telegraph said.
This point of time is not very different from the previously reported schedule.
In the UK, the Pfizer-Bioentech vaccine was approved for the first time in the world, and large-scale vaccinations began on the 8th, and about 500,000 people have been vaccinated so far.
The UK has already ordered 100 million doses of the Oxford University vaccine, and 4 million doses are available immediately.
The vaccine, unlike Pfizer vaccine, can be stored in a regular refrigerator, making it much easier to get vaccinated in thousands of places in the UK, authorities believe. Production is also expected to be made in the UK, making supply easier.
The Korean government also signed a contract to supply 20 million doses of this vaccine.
Meanwhile, the UK authorities had to wait for the submission of the final data for several weeks, as the effect differed depending on the dose difference during the vaccine clinical trial at Oxford University.
After Pfizer’s approval, the Oxford University vaccine will allow millions of vaccinations a week and expect 20 million people to get the vaccine by March next year.